Abeona Therapeutics (ABEO) Non Operating Income (2011 - 2026)

Abeona Therapeutics' Non Operating Income history runs 13 years deep, the most recent figure standing at $50000.0 for Q1 2026.

• In Q1 2026, Non Operating Income fell 64.54% year-over-year to $50000.0; the TTM figure through Mar 2026 stood at $319000.0 (down 72.8% YoY), while the FY2025 annual figure was $410000.0, down 65.66% from the prior year.
• Non Operating Income was $50000.0 for Q1 2026 at Abeona Therapeutics, down from $51000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.2 million in Q2 2023 to a low of -$118000.0 in Q2 2022.
• Historically, Non Operating Income has averaged $296062.5 across 5 years, with a median of $143000.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income surged 1977.12% in 2023, then tumbled 92.31% in 2025.
• A 5-year view of Non Operating Income shows it stood at $277000.0 in 2022, then fell by 22.74% to $214000.0 in 2023, then soared by 209.81% to $663000.0 in 2024, then sank by 92.31% to $51000.0 in 2025, then declined by 1.96% to $50000.0 in 2026.
• The last three Non Operating Income figures came in at $50000.0 (Q1 2026), $51000.0 (Q4 2025), and $129000.0 (Q3 2025), per Business Quant data.